« Previous
Next »
European Journal of Vascular & Endovascular Surgery
Volume 32, Issue 5
, Pages 491-493
, November 2006
Secondary Prevention of Arteriosclerosis in Lower Limb Vascular Amputees: A Missed Opportunity
References
- National Amputee Statistical Database Steering Group. The Amputee Statistical Database for the United Kingdom. 2004.
- . Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice. J Am Geriatr Soc. 1999;47(10):1255–1256
- . The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med. 1997;2(3):221–226
- . Cardiovascular disease in patients with dysvascular amputation. Arch Phys Med Rehabil. 1998;79(2):205–215
- . Rehabilitation outcome 5 years after 100 lower-limb amputations. Br J Surg. 1994;81(11):1596–1599
- . Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. JAMA. 1991;265(9):1145–1151
- West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials. Lancet. 1996;348(9038):1339–1342
- . Clinical perspectives on the role of anti-platelet and statin therapy in patients with vascular diseases. Curr Vasc Pharmacol. 2003;1(3):329–333
- Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease. Circulation. 2003;107(5):757–761
- Statin therapy improves cardiovascular outcome of patients with peripheral artery disease. Eur Heart J. 2004;25(9):742–748
- Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg. 2004;39(5):967–975
- Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality. J Vasc Surg. 2004;39(2):357–365
- Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg. 2004;39(6):1178–1185
- . Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease. Br J Surg. 2001;88(6):787–800
- . Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;136(2):161–172
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348(9038):1329–1339
- Collaborative overview of randomised trials of antiplatelet therapy–II: maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration. BMJ. 1994;308(6922):159–168
- Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis. Eur J Vasc Endovasc Surg. 2000;19(4):370–380
- Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician survey. J Gen Intern Med. 2002;17(12):895–904
- . Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis. CMAJ. 2004;171(10):1189–1192
- Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366(9501):1925–1934
- . Factors influencing rehabilitation of arteriosclerotic lower limb amputees. J Rehabil Res Dev. 1991;28(3):35–44
- . Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation. 2003;108(12):1481–1486
- The early effect of lipid-lowering treatment on carotid and femoral intima media thickness (IMT). Eur J Vasc Endovasc Surg. 2002;23(4):358–364
- Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation. 2003;107(14):1848–1851
- Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet. 2005;366(9500):1849–1861
- British Society of Rehabilitation Medicine. Amputee Rehabilitation: Recommended Standards & Guidelines. 2003.
PII: S1078-5884(06)00387-X
doi: 10.1016/j.ejvs.2006.07.005
© 2006 Elsevier Ltd. All rights reserved.
« Previous
Next »
European Journal of Vascular & Endovascular Surgery
Volume 32, Issue 5
, Pages 491-493
, November 2006
